Prognostic role of preoperative platelet, fibrinogen, and D-dimer levels in patients with non-small cell lung cancer: A multicenter prospective study
- PMID: 30609303
- PMCID: PMC6360242
- DOI: 10.1111/1759-7714.12956
Prognostic role of preoperative platelet, fibrinogen, and D-dimer levels in patients with non-small cell lung cancer: A multicenter prospective study
Abstract
Background: The relationships between coagulation factors and non-small cell lung cancer (NSCLC) prognosis have been intensively studied. However, no previous study has investigated the combined effects of preoperative platelet (PLT), fibrinogen (FIB), and D-dimer (D-D) levels on the prognosis of NSCLC.
Methods: A multicenter prospective study was conducted over seven hospitals. A total of 395 patients diagnosed with operable NSCLC for the first time were included and followed-up until disease progression or the end of the study. Baseline demographic and clinicopathological information, and preoperative coagulation test results were collected for each patient. Univariate and multilevel survival analyses were conducted using Cox regression and shared frailty models.
Results: Multilevel analyses revealed that there was a marginally significant association between elevated PLT level (> 215 × 109 /L) and unfavorable progression-free survival (PFS) (hazard ratio 2.42, P = 0.05), whereas preoperative FIB and D-D were not significant prognostic factors for PFS (P = 0.31 and 0.30, respectively). Compared to patients with one elevation of the three coagulation factors, patients with at least two elevations of the three factors had a significantly higher risk of cancer progression (hazard ratio 4.62, P = 0.02).
Conclusion: The number of elevated preoperative coagulation factors may have a significant effect on PFS and could be used to predict the prognosis of NSCLC patients after surgery. Future studies are warranted to further investigate the interactions between these three coagulation factors.
Keywords: Coagulation; D-dimer; fibrinogen; non-small cell lung cancer; platelet.
© 2019 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
Figures







Similar articles
-
Prognostic role of preoperative D-dimer, fibrinogen and platelet levels in patients with oral squamous cell carcinoma.BMC Cancer. 2021 Feb 5;21(1):122. doi: 10.1186/s12885-021-07841-5. BMC Cancer. 2021. PMID: 33546637 Free PMC article.
-
[Analysis of the factors associated with abnormal coagulation and prognosis in patients with non-small cell lung cancer].Zhongguo Fei Ai Za Zhi. 2014 Nov;17(11):789-96. doi: 10.3779/j.issn.1009-3419.2014.11.04. Zhongguo Fei Ai Za Zhi. 2014. PMID: 25404269 Free PMC article. Chinese.
-
Preoperative plasma D-dimer levels predict survival in patients with operable non-small cell lung cancer independently of venous thromboembolism.Eur J Surg Oncol. 2013 Sep;39(9):951-6. doi: 10.1016/j.ejso.2013.06.008. Epub 2013 Jun 28. Eur J Surg Oncol. 2013. PMID: 23810331
-
Relationship Between Coagulation and Prognosis of Gastric Cancer: A Systematic Review and Meta-Analysis.Curr Ther Res Clin Exp. 2024 Mar 9;101:100741. doi: 10.1016/j.curtheres.2024.100741. eCollection 2024. Curr Ther Res Clin Exp. 2024. PMID: 39628767 Free PMC article. Review.
-
Platelets and their derived extracellular vesicles: The new generation of markers in non-small cell lung cancer management.Drug Discov Today. 2023 Jul;28(7):103616. doi: 10.1016/j.drudis.2023.103616. Epub 2023 May 18. Drug Discov Today. 2023. PMID: 37196761 Review.
Cited by
-
Blood prognostic predictors of treatment response for patients with papillary thyroid cancer.Biosci Rep. 2020 Oct 30;40(10):BSR20202544. doi: 10.1042/BSR20202544. Biosci Rep. 2020. PMID: 33015713 Free PMC article.
-
Application of an elevated plasma D-dimer cut-off value improves prognosis prediction of advanced non-small cell lung cancer.Ann Transl Med. 2020 Sep;8(18):1153. doi: 10.21037/atm-20-5947. Ann Transl Med. 2020. PMID: 33241002 Free PMC article.
-
Impact of fibrinogen levels and modified Glasgow prognostic score on survival of stage III/N2 non-small cell lung cancer patients treated with neoadjuvant therapy and radical resection.BMC Cancer. 2022 Nov 19;22(1):1197. doi: 10.1186/s12885-022-10298-9. BMC Cancer. 2022. PMID: 36403011 Free PMC article.
-
Dynamics of D-dimer in non-small cell lung cancer patients receiving radical surgery and its association with postoperative venous thromboembolism.Thorac Cancer. 2020 Sep;11(9):2483-2492. doi: 10.1111/1759-7714.13559. Epub 2020 Jul 13. Thorac Cancer. 2020. PMID: 32657038 Free PMC article.
-
The prognostic role of a combined fibrinogen and inflammation-based index in patients with metastatic breast cancer.Transl Cancer Res. 2020 Nov;9(11):7065-7078. doi: 10.21037/tcr-20-2157. Transl Cancer Res. 2020. PMID: 35117312 Free PMC article.
References
-
- Chen W, Zheng R, Baade PD et al Cancer statistics in China, 2015. CA Cancer J Clin 2016; 66: 115–32. - PubMed
-
- Ettinger DS, Akerley W, Bepler G et al Non‐small cell lung cancer. J Natl Compr Canc Netw 2010; 8: 740–801. - PubMed
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2018; 68: 7–30. - PubMed
-
- Slebos RJ, Kibbelaar RE, Dalesio O et al K‐ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med 1990; 323: 561–5. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical